rs11564775

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001044.5(SLC6A3):​c.*1097T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.070 ( 18 hom., cov: 0)
Exomes 𝑓: 0.030 ( 0 hom. )

Consequence

SLC6A3
NM_001044.5 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.10

Publications

8 publications found
Variant links:
Genes affected
SLC6A3 (HGNC:11049): (solute carrier family 6 member 3) This gene encodes a dopamine transporter which is a member of the sodium- and chloride-dependent neurotransmitter transporter family. The 3' UTR of this gene contains a 40 bp tandem repeat, referred to as a variable number tandem repeat or VNTR, which can be present in 3 to 11 copies. Variation in the number of repeats is associated with idiopathic epilepsy, attention-deficit hyperactivity disorder, dependence on alcohol and cocaine, susceptibility to Parkinson disease and protection against nicotine dependence.[provided by RefSeq, Nov 2009]
SLC6A3 Gene-Disease associations (from GenCC):
  • classic dopamine transporter deficiency syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • SLC6A3-related dopamine transporter deficiency syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • parkinsonism-dystonia, infantile
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BS2
High Homozygotes in GnomAd4 at 18 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC6A3NM_001044.5 linkc.*1097T>C 3_prime_UTR_variant Exon 15 of 15 ENST00000270349.12 NP_001035.1 Q01959

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC6A3ENST00000270349.12 linkc.*1097T>C 3_prime_UTR_variant Exon 15 of 15 1 NM_001044.5 ENSP00000270349.9 Q01959

Frequencies

GnomAD3 genomes
AF:
0.0697
AC:
3130
AN:
44932
Hom.:
18
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.102
Gnomad AMI
AF:
0.0929
Gnomad AMR
AF:
0.0531
Gnomad ASJ
AF:
0.0616
Gnomad EAS
AF:
0.0388
Gnomad SAS
AF:
0.0521
Gnomad FIN
AF:
0.0648
Gnomad MID
AF:
0.235
Gnomad NFE
AF:
0.0573
Gnomad OTH
AF:
0.0753
GnomAD4 exome
AF:
0.0297
AC:
29
AN:
978
Hom.:
0
Cov.:
0
AF XY:
0.0331
AC XY:
18
AN XY:
544
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
16
American (AMR)
AF:
0.100
AC:
1
AN:
10
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.00
AC:
0
AN:
6
South Asian (SAS)
AF:
0.00
AC:
0
AN:
28
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
272
Middle Eastern (MID)
AF:
0.0482
AC:
19
AN:
394
European-Non Finnish (NFE)
AF:
0.0309
AC:
6
AN:
194
Other (OTH)
AF:
0.0517
AC:
3
AN:
58
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.353
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0697
AC:
3135
AN:
44962
Hom.:
18
Cov.:
0
AF XY:
0.0686
AC XY:
1538
AN XY:
22416
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.102
AC:
1278
AN:
12512
American (AMR)
AF:
0.0534
AC:
256
AN:
4790
Ashkenazi Jewish (ASJ)
AF:
0.0616
AC:
43
AN:
698
East Asian (EAS)
AF:
0.0390
AC:
75
AN:
1924
South Asian (SAS)
AF:
0.0536
AC:
80
AN:
1492
European-Finnish (FIN)
AF:
0.0648
AC:
188
AN:
2900
Middle Eastern (MID)
AF:
0.235
AC:
16
AN:
68
European-Non Finnish (NFE)
AF:
0.0573
AC:
1127
AN:
19680
Other (OTH)
AF:
0.0759
AC:
51
AN:
672
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.353
Heterozygous variant carriers
0
142
285
427
570
712
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.338
Hom.:
363

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
2.0
DANN
Benign
0.068
PhyloP100
-2.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11564775; hg19: chr5-1393753; API